MedPath

PROLOPA CAP 200-50

PROLOPA CAP 200-50

Approved
DIN Number

00386472

Drug Class

Human

Market Date

Dec 31, 1977

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00386472
AIG Number0211634002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:36.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)Active
Strength: 50 MG
Monograph: BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)
LEVODOPAActive
Strength: 200 MG
Monograph: LEVODOPA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.